Early Findings of AI Study at Frimley Health NHS Foundation Trust Show 99.7% Accuracy in Triaging Chest X-rays as Normal

Qure.aiFrimley Health NHS Foundation Trust and Qure.ai have announced the early results of a pilot study using an innovative radiology AI solution to read and differentiate between normal and abnormal chest X-rays (CXRs).

qXR, a CE class IIb MDR cleared solution developed by Qure, was deployed with the hypothesis to categorise normal x-rays - approximately 40% of the caseload from GP and outpatient requests - and augment overall reporting efficiency. The aim of the study was to highlight AI’s potential role in optimising radiology department workflows, to boost efficiency and enhance patient outcomes.

Early results show 99.7% accuracy in triaging CXRs as normal, with the potential to reduce consultant radiologist’s workload by up to 58% by transferring cases to radiographer reporting workload. This could save consultant radiologists up to 2 hours per day, freeing up time to concentrate on specialist and complex imaging reports.

Additionally, the qXR AI identified all cancer cases, including inconspicuous cancer risk nodules that may traditionally remain unnoticed. This heralds the potential of using AI for early detection and treatment of lung cancer.

Dr Amrita Kumar, Consultant Radiologist and AI Clinical Lead at Frimley Health NHS Foundation Trust states, "AI offers a transformative advantage to Frimley Health NHS Foundation Trust, enabling efficient triage of normal chest X-rays and empowering radiologists to focus on complex cases. By optimising efficiency, Qure's qXR Chest X-ray solution contributes to better patient outcomes and addresses the critical need for innovative AI solutions in the radiology department."

Darren Stephens, Senior Vice President & Commercial Head UK and Europe of Qure.ai comments, "The ongoing radiologist shortage, now estimated by Royal College of Radiologists to be 40% by 2027, underscores the importance of healthcare AI to help augment the precious human resource that currently exists, and ensure the delivery of the highest standard of patient care into the future. The qXR study at Frimley Health NHS Foundation Trust is testimony to the clinical leadership at the Trust in embracing AI as an opportunity for positive change."

For further information, please visit:
https://qure.ai

About Qure.ai

Qure.ai is a health tech company that uses deep learning and Artificial Intelligence (AI) tools to make healthcare more accessible and affordable to patients around the world in medical imaging & care coordination. Our technology fulfils a pertinent, unmet need in the radiology industry. With the aid of tools like those developed by Qure.ai, which work via a sophisticated set of algorithms that can instantly evaluate scans to prioritize actionable patient cases quickly, radiologists can focus their time and advanced skill sets on the most pressing diagnoses.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...